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Abstract In this systematic review and meta-analysis we
investigated the effectiveness of different psychosocial
treatments for people living with HIV (PLWH) and mental
health problems. Additionally, characteristics that may
influence the effectiveness of a treatment (e.g., treatment
duration) were studied. PubMed, PsycINFO and Embase
were searched for randomized controlled trials on psy-
chosocial interventions for PLWH. Depression, anxiety,
quality of life, and psychological well-being were investi-
gated as treatment outcome measures. Sixty-two studies
were included in the meta-analysis. It was found that
psychosocial interventions for PLWH had a small positive
effect on mental health (gˆ = 0.19, 95% CI [0.13, 0.25]).
Furthermore, there was evidence for publication bias. Six
characteristics influenced the effectiveness of a treatment
for depression. For example, larger effects were found for
studies with psychologists as treatment providers. To
conclude, this systematic review and meta-analysis sug-
gests that psychosocial interventions have a beneficial
effect for PLWH with mental health problems.
Resumen En esta revisio´n sistema´tica y meta-ana´lisis se
ha investigado la efectividad de los diferentes tratamientos
psicosociales para las personas viviendo con VIH (PVVIH)
y con problemas de salud mental. Adicionalmente, hemos
estudiado las caracterı´sticas que pueden influir en la efec-
tividad de un tratamiento (por ejemplo, duracio´n del tra-
tamiento). Como medidas de tratamiento, pruebas
controladas aleatorizadas de las intevenciones psicosocia-
les para depresio´n, ansiedad, calidad de vida y bienestar
psicolo´gico fueron buscadas en PubMed, PsycINFO y
Embase. Sesenta y dos estudios se han incluido en el
metana´lisis. Hemos encontrado que intervenciones psico-
sociales para las PVVIH tuvieron un menor efecto positivo
en la salud mental (gˆ = 0.19, IC del 95% [0.13, 0.25]).
Adema´s, hubo evidencia de sesgo en la publicacio´n. Seis
caracterı´sticas influyeron la efectividad del tratamiento
para la depresio´n. Por ejemplo, hemos encontrado efectos
mayores en estudios con psico´logos como proveedores del
tratamiento. Concluyendo, esta revisio´n sistema´tica y
meta-ana´lisis indica que las intervenciones psicosociales
tienen un efecto beneficioso para gente con PVVIH y con
problemas de salud mental.
Keywords HIV  Psychosocial intervention  Mental
health  Depression  Meta-analysis
Introduction
In recent decades, due to the use of antiretroviral medica-
tion, HIV has become a chronic illness instead of a disease
that rapidly leads to severe sickness and death. However,
people living with HIV (PLWH) may still suffer from
physical symptoms, such as pain and lack of energy [1]. In
addition, mental health problems such as depression and
anxiety are common among PLWH [2–4]. In PLWH, the
prevalence rate of mood disorders or clinically significant
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depressive symptoms is approximately 33% [5], and the
prevalence rate of anxiety disorders about 20% [6]. Several
psychosocial factors—such as isolation, stigma, discrimi-
nation, lack of support, and drug abuse—can contribute to
feelings of depression and anxiety [4, 7]. In turn, mental
health problems may have various negative consequences
for PLWH. For example, it has been shown that PLWH
with depressive symptoms have a higher risk of poor
adherence to antiretroviral therapy (ART); they are also
more at risk for HIV-related morbidity and mortality [8].
More specifically, in PLWH psychological factors (such as
depressive symptoms and stress) have been shown to be
related to immune measures, such as decreased cluster of
differentiation 4 (CD4) cell count and increased viral load
[9, 10]. In view of the above research, it seems apparent
that depression and anxiety in PLWH may decrease well-
being and quality of life [11].
Given the impact that psychological symptoms have on
the health and well-being of PLWH, it is very important to
treat these symptoms. Several psychosocial interventions,
such as cognitive behavioral therapy (CBT), supportive
interventions, meditation, and stress management inter-
ventions, have been developed for PLWH with mental
disorders. Various reviews and meta-analyses have found
that these interventions are effective in reducing symptoms
of depression, anxiety, and distress in PLWH [12–18]. The
format of these interventions may differ from a group-
based or individualized format to interventions where the
PLWH’s partner or other family members are also
involved. In addition to assessing the overall effectiveness
of various psychosocial interventions, it is also important to
compare interventions with each other and determine
whether specific interventions stand out as the most
effective to improve mental health in PLWH. With this
information, more targeted treatment may be provided in
the future. The interventions that seem to be the most
effective could be offered first, which might improve the
psychological care of PLWH. However, previous meta-
analyses and reviews [12, 13, 15–18] have not compared
interventions with each other to discover which specific
psychosocial interventions are the most effective for
PLWH with mental health problems.
Additionally, it is also meaningful to investigate whe-
ther certain characteristics may influence the effectiveness
of the treatment. We can distinguish two types of charac-
teristics that may act as moderators. The first type are
characteristics of the intervention, such as treatment dura-
tion, intervention techniques, or the provider of the therapy.
If we have more knowledge about the effect of treatment
characteristics on the effectiveness of an intervention, this
can be used to improve existing interventions by including
the most beneficial aspects when designing new interven-
tions for PLWH with mental health problems. If we find,
for example, that interventions provided online or by a
psychologist are more effective than interventions provided
by others (e.g., peers), it may be useful to design new
interventions that are provided online or by psychologists.
The second type of possible moderators are characteristics
of the study, such as the sample that was used or the type of
control group. These characteristics may partly explain
why some studies find larger effects than others. For
instance, it may be that studies with many female partici-
pants show larger effects than studies with many males. If
this is the case, it may be useful to consider this aspect in
future studies. As yet, not much research is available about
moderators of treatment effect in PLWH. However, mod-
erating factors were taken into account in one meta-anal-
ysis, which found that stress-management interventions for
PLWH reduced anxiety symptoms. In this research, the
effect of the intervention was found to be larger when they
included more women, more participants with anxiety
symptoms at baseline, younger participants, and made less
use of medication adherence information and/or planning
in an intervention [16].
Most previous meta-analyses have focused on particular
psychological interventions (e.g., CBT or meditation) and
mostly also on a particular outcome (such as alleviation of
depression or anxiety) [12–18]. However, no meta-analysis
has yet investigated which psychosocial interventions are
the most effective on psychological outcomes. The first aim
of the present systematic review and meta-analysis was to
investigate this. This meta-analysis included various psy-
chosocial interventions for PLWH, including CBT, support
interventions (e.g., peer support), interpersonal psy-
chotherapy, stress management, mindfulness, coping
improvement interventions, and family interventions. In
addition, multiple outcomes were studied: depression,
anxiety, quality of life, and psychological well-being. Only
randomized controlled trials (RCTs) were included in the
meta-analysis. As it is important to investigate moderators
of intervention effect, and this was not examined in detail
in previous meta-analyses, the second aim of the current
meta-analysis was to carry out a moderator analysis. Since
we included a lot of different intervention types and out-
comes, we expected that there would be large differences
between study effect sizes. A moderator analysis could
give more information about which characteristics might
explain these differences in results. Various possible
moderators were included: intervention characteristics such
as intervention duration, therapy provider, and intervention
techniques (e.g., stress-management); and study charac-
teristics such as attrition, study quality, and sample char-
acteristics. To conclude: we investigated and provide an
overview of the effectiveness for PLWH of psychosocial
interventions in decreasing depression and anxiety and
improving quality of life and psychological well-being. In
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addition, we investigated whether specific interventions
stood out as having the greatest effect on these outcomes
and we studied moderators of intervention effect.
Methods
Search Strategy and Study Selection
Several strategies were used to search for relevant RCTs.
First, we searched in the electronic databases PubMed,
PsycINFO, and Embase on September 29, 2014. Search
words included terms related to HIV/AIDS, various types
of psychosocial interventions (e.g., CBT, psychotherapy),
and outcomes (e.g., depression, quality of life). The search
strategy with keywords can be found in the Appendix.
Second, we also searched for papers in the references of
available meta-analyses and reviews about the subject.
Studies were included when they met all of the fol-
lowing criteria: (1) RCT; (2) evaluation of a psychosocial
intervention (see definition below); (3) participants in the
study are HIV positive and are 18 years or older; (4) year
of data collection is later than 1995 (see explanation
below); (5) the outcome variables that were studied belong
to one or more of the following categories: depression,
anxiety, psychological well-being, or quality of life; (6)
studies were written in the English language; and (7) data
to calculate effect sizes was present in the paper or
retrieved from the authors. Regarding the second inclusion
criterion, a psychosocial intervention was operationalized
as an intervention that aimed to change thoughts, emotions
and/or behavior of PLWH and had a psychosocial com-
ponent. Therefore, physical interventions (such as exer-
cise), were not included in the meta-analysis. Regarding
the fourth inclusion criterion, we decided to include studies
that collected data later than 1995, since antiretroviral
medication was developed in 1996 and consequently the
future prospects of PLWH changed a lot after that period.
Furthermore, the outcome domains depression, anxiety and
quality of life were specified a priori. Only the outcome
psychological well-being was first intended for stress-re-
lated outcomes, but this was a rather small category, so we
decided to enlarge it. Positive and negative affect, psy-
chological functioning and general mental health were
examples of concepts that were included in the outcome
psychological well-being. Studies that had posttraumatic
stress disorder (PTSD) as an outcome were not included in
the meta-analysis. Regarding the seventh criterion, authors
of the included papers were contacted to retrieve data that
was not available in the paper. When the authors did not
respond to the requests (even after reminder e-mails) and
the data to calculate effect sizes was not available, the
study was not included in the meta-analysis.
The first step was the selection of studies on title and
abstract, and was performed by two persons (first and
fourth author). The first 100 studies were selected by
both authors independently, to determine the agreement
among selectors, which was substantial [19], Cohen’s
kappa = 0.80. Thereafter, both selected half of the
remaining studies. For the second step of selecting
studies, based on full text, the studies were divided
among three persons (first and fourth author and a Master
student in clinical psychology). The inclusion criteria, as
described above, were used in the following order to
ensure a fast and equal decision: 6, 3, 1, 4, 2, 5, 7. When
there was doubt about including a study, the paper was
discussed with one or more of the other authors to make
a decision.
Problems of Multiplicity
Some decisions had to be made when multiple papers were
published about the same data or when multiple measuring
instruments, time points or interventions were used in one
study. When there were multiple papers about the same
data, the paper with the most relevant outcome data was
used as the main paper. Other papers were used to add
information that was not present in the main paper. In
addition, when there were multiple measuring instruments
for one outcome, two instruments were included in the
analysis and their data was averaged. The instruments that
were most validated and comparable to other studies were
chosen. When there were assessments at more than one
time point after the termination of the intervention, the first
time point (first post-test) was included in the main anal-
ysis. Moreover, we did investigate overall differences
between time points post intervention. For this analysis,
time points were classified into these categories:
0–3 months post intervention, more than 3–6 months post
intervention, more than 6–9 months post intervention, and
more than 9 months post intervention. When two assess-
ments occurred in one time period, both were included in
the analysis and the data was averaged. At last, when there
were multiple intervention and/or control conditions in a
study, they were all included in the analysis and coded as
intervention or control conditions. In the analysis con-
cerning the overall effectiveness of psychosocial inter-
ventions on mental health, the data of multiple intervention
conditions was averaged. To investigate which interven-
tions and techniques were most effective in the moderator
analysis, all interventions were investigated separately.
Therefore, some studies were represented multiple times in
this analysis. To be included as an intervention condition,
the intervention should have a psychosocial component. In
the control condition, people were put on a waiting list,
received standard care or were in an active control
AIDS Behav (2018) 22:9–42 11
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condition. This last category included for example (psy-
cho)education, support and telephone check-ups.
Data Extraction and Coding
We developed a protocol to extract the data from the
articles. The following information was extracted from the
papers: year of publication, baseline scores on outcome
variables, post-treatment results, follow-up results, country
of data collection, years of recruitment, study setting (in-
patient; outpatient; combination), number of participants in
each group, percentage attrition, percentage females, mean
age, percentage MSM, percentage participants with AIDS,
mean number of years with HIV, percentage participants
that use ART, screening on depression (yes; no), inter-
vention type (symptom-oriented intervention; supportive
intervention; meditation intervention), intervention tech-
niques (relaxation; CBT; motivational interviewing; stress-
management), intervention duration (total duration in
hours; duration in weeks; number of sessions; duration of
one session), therapy provider [psychologist/psychothera-
pist; counsellor (e.g., nurse, HIV specialist, social worker,
trained facilitator); peer; none (e.g., computer); other],
intervention format [group; individual; combination; other
(e.g., family interventions)], primary focus of intervention
(mental health; no mental health), primary outcome
(mental health; no mental health), theory content of inter-
vention (theory-driven; not theory-driven), type of control
group (waiting list; standard care; active control group),
length of follow-up, type of analysis [intent-to-treat (ITT);
no ITT], and study quality (see next paragraph).
The intervention type variable included three categories:
symptom-oriented interventions, supportive interventions
and meditation interventions. These categories were cre-
ated post hoc, after examining the content of the included
interventions. The category symptom-oriented interven-
tions included mostly cognitive and/or behavioral therapy,
stress-management, and interpersonal therapy. Further-
more, the category supportive interventions consisted of
(peer) support and psycho-education, and the category
meditation interventions included interventions that incor-
porated mindfulness, meditation, or relaxation. Since the
symptom-oriented interventions used various psychologi-
cal techniques, it was further investigated whether symp-
tom-oriented interventions that used a specific technique
would have larger effects than symptom-oriented inter-
ventions that did not use this specific technique. This was
investigated in the symptom-oriented interventions only,
because the supportive and meditation interventions mostly
did not make use of additional psychological techniques.
The assessed intervention techniques were relaxation, CBT
(defined as containing cognitive and/or behavioral tech-
niques), motivational interviewing and stress-management.
One symptom-oriented intervention may use multiple
psychological techniques. For example, a symptom-ori-
ented intervention may include CBT techniques and
relaxation techniques. The explanation of intervention
types and intervention techniques is depicted in Table 1.
The variable theory content of intervention contains two
categories: (1) it was described that the intervention was
based on theory or a theoretical model (e.g., social cogni-
tive theory or the health belief model) or (2) it was not
described that the intervention was based on theory or a
theoretical model. The type of control group was catego-
rized as waiting list, standard care or an active control
condition. Standard care included for example standard
medical care and referral to mental health services when
needed. The last category included for instance (psy-
cho)education, support and telephone check-ups.
The following information was asked from the authors,
when it was not available in the paper: baseline, post-
treatment and follow-up data, years of recruitment, number
of participants in each group, percentage attrition, per-
centage females, mean age, intervention duration, therapy
provider, intervention format, type of control group, length
of follow-up and type of analysis. The data was extracted
by two persons (first author and a psychologist). Both
coded a portion of the studies and 17 of the studies (27%)
were coded by both authors. The intraclass correlation
coefficient was calculated for the agreement on continuous
variables, which was 0.99. For the categorical variables a
Cohen’s kappa was calculated, this was 0.72, which is
substantial.
Study Quality
Study quality was assessed by using two methods: the
Cochrane Collaboration’s tool for assessing risk of bias
[20] and three criteria from a review about defining
empirically supported psychological treatments [21]. The
Cochrane Collaboration’s tool for assessing risk of bias
consists of six domains. Four domains were used in this
study: (1) sequence generation for allocation to conditions;
(2) concealment of allocation to conditions; (3) addressing
incomplete outcome data; and (4) selective outcome
reporting. The domain blinding of participants and
researchers was not used, because in almost all studies
participants and researchers could not be blinded to the
allocation to conditions. Furthermore, the domain other
sources of bias was not used, because in most studies there
were no other sources of bias. On each domain, a study
received the judgement low risk of bias (?), high risk of
bias (-) or unclear risk of bias (?) using the criteria from
the tool.
Furthermore, we used three criteria from a review about
defining empirically supported psychological treatments, to
12 AIDS Behav (2018) 22:9–42
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assess the quality of administering the intervention: (1) the
availability of a treatment manual that was followed
(published or designed for the study); (2) the use of a
training for the therapy providers (for the study or general
training); and (3) treatment integrity was checked during
the study (e.g., supervision of therapy providers, recording
of sessions, checking of protocol adherence). For each
criterion a study received a judgement of yes (?, low risk
of bias), no (-, high risk of bias), unclear (?) or not
applicable (NA; e.g., when the intervention is a self-help
program). Two persons (first author and a psychologist)
rated the quality of the studies. Both rated a portion of the
studies and 17 studies were rated by both authors to cal-
culate their agreement. Cohen’s kappa was 0.67, which is
substantial.
Moderators
The following moderators were investigated: country of
data collection, first year of participant recruitment, per-
centage attrition, percentage females, mean age, percentage
MSM, percentage participants with AIDS, mean number of
years with HIV, percentage participants that use ART,
screening on depression, intervention techniques, inter-
vention duration, therapy provider, intervention format,
primary focus intervention, primary outcome mental
health, theory content of intervention, type of control
group, type of analysis and study quality.
For the moderator analyses with continuous variables,
the assumptions for meta-regression were checked (nor-
mality and linearity). None of the variables met both
assumptions. Therefore, the continuous variables were
transformed into categorical variables. The categorization
was based on statistical and content related reasons. The
variable first year of recruitment was categorized into three
periods: 1996–2001, 2002–2006 and 2007–2012. The
variable percentage of drop-out was separated into three
categories: 0–10, 10–20 and [20%, as was the variable
percentage of females: 0–20%, 20–80 and 80–100%. The
variable mean age was divided based on a median split:
\42.40 and C42.40 years. The variable percentage MSM
was divided into two categories: 0 and[0% (because most
studies had no MSM, so the median was 0%). The variable
percentage of people with AIDS was separated into two
categories based on a median split:\40 and C40%, as was
the variable number of years with HIV: \10.02 and
C10.02 years and the variable percentage of people on
ART: \87 and C87%. Finally, the variable total inter-
vention duration was divided into four categories: 1–5,
5–12, 12–18 and 18–30 h.
Study quality was included as a moderator in the anal-
ysis. When a study met 0–2 out of seven quality criteria
(0–2 times a ?), the study was classified as a study with
low quality. When a study met 3–4 quality criteria, the
study was classified as a study with medium quality and
when 5–7 criteria were met, the study was classified as a
study with high quality. A rating of unclear risk of bias was
scored as a high risk of bias (-) in this classification. For
studies with a judgement of NA on the three criteria
regarding the quality of administering the intervention, a
low quality rating was given to studies which had a low
risk of bias rating on 0–1 on the four other quality criteria,
a medium quality rating was given to studies which had a
low risk of bias on 2 of the other quality criteria and a high
quality rating was for the studies which had a low risk of
bias on 3–4 of the other quality criteria.
Data Analysis
The program comprehensive meta-analysis (CMA; version
3) was used for the analysis. Hedges’ g was calculated as a
measure of effect size. Baseline, post intervention and
follow-up means, standard deviations, sample sizes and/or
other available data were used to calculate effect sizes (e.g.
F, t or p values). One study [22] reported median decreases
in depression scores, instead of mean decreases. These
medians were entered into CMA, because the means could
not be retrieved. Also, five studies [23–27] found no dif-
ferences between intervention and control conditions on
one or more outcome measures, but no data was available.
The effect sizes of these outcome measures of the studies
were set at zero. Cohen’s guidelines were applied to
Table 1 Intervention types and intervention techniques
Intervention types Intervention techniques (in symptom-oriented
interventions only)
Symptom-oriented intervention (e.g., cognitive and/or behavioral therapy, stress-
management, interpersonal therapy)
Relaxation
Supportive intervention (e.g., support, psycho-education) CBT
Meditation intervention (e.g., mindfulness, meditation, relaxation) Motivational interviewing
Stress-management
AIDS Behav (2018) 22:9–42 13
123
interpret effect sizes: 0.2 may indicate a small effect size,
0.5 may indicate a medium effect size and 0.8 may indicate
a large effect size [28]. Two-tailed p-values were used in
all analyses. In CMA, a correlation between pre- and
posttest should be indicated for each study. Since this
correlation was rarely reported in study papers, this was set
at 0.5 (as suggested by [29]). Standardized residuals were
inspected to find outliers, defined as studies with stan-
dardized residuals larger than |3| [30].
A random effects model was used for the main analysis
to estimate the pooled effect size of psychosocial inter-
ventions on mental health (expressed as Hedges’ gˆ).
Separate analyses were conducted for each outcome (de-
pression, anxiety, quality of life, and psychological well-
being), intervention type (symptom-oriented intervention,
supportive intervention, and meditation intervention) and
time point (0–3 months post intervention, 3–6 months post
intervention, 6–9 months post intervention, and[9 months
post intervention). The random effects model was used
because we assumed heterogeneity across studies. To
investigate the presence and amount of heterogeneity,
Q and I2 were calculated. When Q is significant, this means
that the results of the studies are probably not consistent.
The amount of heterogeneity can be identified with I2.
Values of 25% indicate low heterogeneity, 50% indicates
moderate heterogeneity and 75% indicates high hetero-
geneity [31].
For the moderator analysis, a mixed effects model was
used, in which the random effects model was used to
combine studies in one subgroup and a fixed effects model
was used to compare across subgroups [32]. In CMA, the
mixed and random effects option was set to: do not assume
a common among-study variance component across sub-
groups (do not pool within-group estimates of tau-squared).
To examine the presence of publication bias different
methods were used. First, a funnel plot was created, where
the standard error is plotted as a function of effect size.
Studies with small standard errors (large studies in general)
are displayed at the top of the plot and studies with large
standard errors (small studies in general) are displayed at
the bottom of the plot. When the studies are symmetrically
distributed around the pooled effect size estimate, there is
no indication of publication bias. When it seems that
studies are missing on the lower left side, this may be an
indication of publication bias (small studies with results
lower than the pooled estimate are missing). Second,
Egger’s test of the intercept [33] was used to statistically
test for publication bias. There is an indication of publi-
cation bias when the test is significant. Last, Duval and
Tweedie’s trim and fill analysis [34] was used to investi-
gate whether it was necessary to impute studies in the
funnel plot due to publication bias. After the imputation of
missing studies, an adjusted effect size was calculated.
Results
Through electronic databases, 905 articles were identified
(see flow-chart of study inclusion and exclusion in Fig. 1).
After removal of duplicates (228), 677 articles were
screened on title and abstract. Thereafter, 197 articles were
screened on full text. After this screening, 64 studies met
the inclusion criteria. In addition, three studies were found
in previous meta-analyses and systematic reviews. From 20
of the 67 studies, data to calculate effect sizes was not
present in the paper. Therefore, the authors were contacted
to obtain these data. Of 15 studies, the authors were able to
provide the data, one author could not provide the data, the
authors of one study did not want to be included in the
meta-analysis (because study aim did not fit with the aim of
the meta-analysis), and three authors did not respond. In
total, 62 studies were included in the meta-analysis.
Study Characteristics
The characteristics of all included studies are presented in
Table 2. In total, 10,307 participants were randomized to
intervention and control conditions (range 12–936;
k = 62). Drop-out (the percentage of participants that did
not complete the first posttest) ranged from 0 to 55%, with
a mean of 18% (SD = 11.93; k = 58). Seven studies (7/60)
included only males and 13 included only females, the
percentage of females in the included studies was 44% on
average (SD = 34.54). The mean of the mean age of par-
ticipants across studies was 42.01 years (SD = 5.98, range
of the mean: 26.00–59.00 years, k = 54). The mean per-
centage of MSM in the studies that reported on it was 31%
(SD = 38.27; k = 22). Across the studies that documented
it, the mean percentage of people with AIDS was 45%
(SD = 28.59; k = 15) and the mean duration of HIV was
9.81 years (SD = 3.59, range of the mean: 0–18 years;
k = 28). Most participants in the studies that reported on it
used ART, the mean percentage of people that used it is
76% (SD = 34.28; k = 28). For some characteristics, the
number of studies that reported on it was very low.
Therefore, these results should be interpreted with caution.
The majority of studies was conducted in the USA and
Canada (k = 46). Other countries of data collection were
China, Iran, Kenya, Nigeria, South Africa, Switzerland,
Tanzania, Thailand, The Netherlands, Uganda, and Viet-
nam. One study recruited participants in the USA and
Mexico and one study in South Africa, Puerto Rico, and the
USA. The years of participant recruitment ranged from
1996 to 2013 (k = 57). The majority of studies was con-
ducted in an outpatient setting (58/62), only two studies
were conducted in an inpatient setting and two studies
combined inpatients and outpatients. Ten studies (10/62)
14 AIDS Behav (2018) 22:9–42
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incorporated the presence of depressive symptoms as an
inclusion criterion. In the majority of studies (54/62),
mental health (i.e., depression, anxiety, quality of life, or
psychological well-being) was a primary outcome measure.
Depression was measured in 47 studies, anxiety in 22,
quality of life in 19, and psychological well-being in 25
studies. Some studies (31/62) used an active control con-
dition, 9 studies used a waiting list condition, and 22
studies had a standard care control condition. Furthermore,
more than half of the studies (32/51) used an ITT analysis,
and included one or more follow-up assessments (40/62);
22 studies had one follow-up, 16 studies had two follow-
ups, one study had 3 follow-ups, and one study had 4
follow-ups. The timing of follow-ups ranged from 1 to
17 months after treatment completion.
Intervention Characteristics
The description of intervention characteristics was based
on all interventions, so eight studies [46, 52–54, 61, 64, 87,
91] were represented twice in this analysis and one study
[65] was represented three times, because multiple inter-
ventions were investigated in these studies. The letter m
will be used to indicate the number of interventions.
Regarding intervention types (see Table 1), a majority of
the interventions were symptom-oriented (41/72), the rest
were supportive (20/72), or meditation interventions (11/
72). Regarding techniques used in symptom-oriented
interventions (m = 41), CBT techniques were used in 29
interventions, relaxation techniques in 14, stress-manage-
ment techniques in 16, and finally motivational inter-
viewing techniques in 6 interventions. Almost two-thirds of
the interventions (47/72) were focused on one of our out-
come measures (depression, anxiety, quality of life, or
psychological well-being). Studies that investigated inter-
ventions that were not focused on one of our outcome
measures, were often aimed at medication adherence or
sexual risk behavior, and sometimes at coping, disclosure,
general health, family functioning, posttraumatic stress
disorder symptoms, or smoking. A majority (44/72) of the
interventions were theory-driven and 28 interventions were
not theory-driven. Concerning the duration of the inter-
ventions, the total length ranged from 1 to 30 h (m = 62),
with a mean of 12.63 (SD = 8.46). The duration of the
intervention in weeks ranged from 1 to 54 (M = 12.20,
SD = 13.27, m = 66) and the number of sessions ranged
from 1 to 48 (M = 9.92, SD = 8.62, m = 67). The average
length of one session was 1.37 h (SD = 0.66, range 15 min
Fig. 1 Flow chart of study inclusion and exclusion
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to 3 h, m = 63). Providers of the interventions were psy-
chologists/psychotherapists (18/65), counsellors (e.g., nur-
ses, 29/65), peers (4/65), none (e.g., computer
interventions, 9/65), and other (e.g., investigators, 5/65).
The format of the intervention was either individual (31/
72), group (30/72), a combination of individual and group
(6/72), or other (e.g., family interventions, 5/72).
Quality of the Included Studies
The quality ratings of the studies are presented in Table 3.
The first quality criterion, regarding the sequence genera-
tion for allocation to conditions, was reported in more than
half of the studies (32/62), in the other studies it was
unclear. The criterion about the concealment of allocation
to conditions was often not reported, only 13 studies
mentioned it, in the other studies it was unclear. Incomplete
outcome data (the third criterion) was adequately addressed
in half of the studies (31/62, e.g., with an ITT analysis), in
20 studies it was not adequately addressed and in 11 studies
this was not clear. For most studies (58/62) there was no
study protocol available, so the criterion of selective out-
come reporting was unclear, only four studies had a rating
of low risk of bias on this criterion.
Eight studies investigated an intervention without a
provider (e.g., computer or self-help interventions). These
studies were not coded on the quality of the administered
intervention. In 36 of the 54 studies a treatment manual
was available and followed and in 18 studies this was not
described. Trained providers were used in 36 of the 54
studies, in 17 studies this was unclear and one study
explained that they did not make use of trained providers.
Finally, in 31 of the 54 studies treatment integrity was
checked and in 23 studies this was not described. A sum-
mary of the ratings on all quality criteria is presented in
Fig. 2. Regarding the overall quality classification, most
studies were classified as low (24/62) or medium (28/62)
quality. Only 10 studies were classified as high quality.
None of the studies met all quality criteria, but five studies
met all except one criterion.
Intervention Effectiveness
The overall effect of psychosocial interventions on mental
health outcomes was Hedges’ gˆ = 0.19, 95% CI [0.13,
0.25], p\ 0.001 (see Fig. 3). Thus, psychosocial inter-
ventions may have a positive effect on mental health,
compared to a control condition. However, the effect size
was small. Standardized residuals were inspected to iden-
tify outliers (studies with standardized residuals |3|), but
none were found.
Table 4 shows the overall effect of psychosocial inter-
ventions on mental health and the effect sizes for each
outcome, intervention type and time point separately. It
shows that the pooled effect sizes for depression and psy-
chological well-being were larger (gˆ = 0.21 and 0.20) than
those for anxiety and quality of life (gˆ = 0.09 and 0.13).
Furthermore, heterogeneity was moderate and significant
for the outcomes depression and psychological well-being
and smaller and not significant for anxiety and quality of
life. Therefore, we decided to conduct the moderator
analysis only on the outcomes depression and psycholog-
ical well-being. Results are presented for the moderator
analyses on depression and differences with the moderator
analyses of psychological well-being will be discussed.
The results regarding intervention type (categories:
symptom-oriented intervention, supportive intervention,
and meditation intervention; Table 4) show that each
intervention type had a pooled effect size of approximately
gˆ = 0.20. The analysis on time points shows that the first
and third time point had pooled effect sizes of gˆ = 0.18,
while the second (gˆ = 0.13) and last (gˆ = 0.08) time point
had smaller pooled effect sizes. The pooled effect size of
the last time point was not significant and it should be
noted that it was based on only nine studies. In sum, the
overall effect of psychosocial interventions on mental
health outcomes was small (gˆ = 0.19).
Intervention Effectiveness: Analysis on Last Time
Point
The analysis on outcome type and intervention type
described above was also conducted with the last available
time point for each study, instead of the first time point.
The analysis on the last time point was conducted, as we
were also interested in the results on the long term, next to
the results on the short term. Differences between those
analyses were examined and will be depicted here. The
overall effect of psychosocial interventions on mental
health was comparable, gˆ = 0.18, 95% CI [0.12, 0.25],
p\ 0.001; Q = 110.25, p\ 0.001, I2 = 45%. The pooled
effect size on the outcome of anxiety was somewhat larger
in this analysis, gˆ = 0.14, 95% CI [0.02, 0.25], p\ 0.05
and heterogeneity was significant, Q = 39.44, p\ 0.01,
I2 = 47%. The pooled effect size on the outcome psy-
chological well-being was comparable, but heterogeneity
was smaller and not significant in this analysis, Q = 34.06,
p = 0.08, I2 = 30%. Furthermore, the effects of supportive
interventions (gˆ = 0.18, 95% CI [0.04, 0.33], p\ 0.05)
and meditation (gˆ = 0.16, 95% CI [0.02, 0.31], p\ 0.05)
were somewhat smaller in this analysis and the effect of
symptom-oriented interventions was larger (gˆ = 0.21, 95%
CI [0.14, 0.28], p\ 0.001). Summarizing, the analysis on
the first time point and the analysis on the last time point
were comparable and only small differences were found.
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Table 3 Quality of the included studies
Study Sequence
generation
Allocation
concealment
Incomplete
outcome
data
Selective
outcome
reporting
Availability of
treatment
manual
Use of training
for therapy
providers
Treatment
integrity was
checked
Quality
classificationa
Balfour et al.
[35]
? ? ? ? ? ? ? High
Berger et al.
[36]
? ? ? ? ? ? ? High
Boivin et al.
[37]
? ? ? ? ? ? ? Low
Boivin et al.
[38]
? ? ? ? ? ? ? Medium
Bormann et al.
[39]
? ? ? ? ? ? ? Medium
Brazier et al.
[23]
? ? – ? ? ? ? Low
Brown et al.
[40]
? ? ? ? NA NA NA Medium
Carrico et al.
[41]
? ? ? ? ? ? ? Medium
Carrico et al.
[42]
? ? ? ? ? ? ? Medium
Chan et al. [43] ? ? – ? ? ? ? Low
Chang et al.
[44]
? ? ? ? NA NA NA High
Chhatre et al.
[45]
? ? – ? ? ? ? Low
Coˆte´ and
Pepler [46]
? ? – ? ? ? ? Low
Duncan et al.
[47]
? ? ? ? ? ? ? Low
Eller et al. [48] ? ? ? ? NA NA NA Low
Erlen et al. [49] ? ? ? ? ? ? ? Low
Fife et al. [50] ? ? – ? ? ? ? Low
Gayner et al.
[51]
? ? ? ? ? ? ? Medium
Heckman and
Carlson [52]
? ? ? ? ? ? ? Medium
Heckman et al.
[53]
? ? ? ? ? ? ? Medium
Heckman et al.
[54]
? ? ? ? ? – ? Medium
Hersch et al.
[55]
? ? ? ? NA NA NA Low
Ironson et al.
[56]
? ? ? ? NA NA NA Low
Jensen et al.
[57]
? ? ? ? ? ? ? Medium
Kaaya et al.
[58]
? ? – ? ? ? ? Medium
Kalichman
et al. [59]
? ? – ? ? ? ? Medium
Klein et al.
[60]
? ? ? ? NA NA NA Medium
Kraaij et al.
[61]
? ? – ? NA NA NA Low
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Table 3 continued
Study Sequence
generation
Allocation
concealment
Incomplete
outcome
data
Selective
outcome
reporting
Availability of
treatment
manual
Use of training
for therapy
providers
Treatment
integrity was
checked
Quality
classificationa
Lechner et al.
[62]
? ? – ? ? ? ? Medium
Li et al. [63] ? ? ? ? ? ? ? Low
Lovejoy [64] ? ? ? ? ? ? ? High
McCain et al.
[65]
? ? ? ? ? ? ? High
Miles et al.
[66]
? ? ? ? ? ? ? Medium
Miller et al.
[67]
? ? – ? ? ? ? Low
Mitrani et al.
[68]
? ? ? ? ? ? ? Medium
Murphy et al.
[69]
? ? – ? ? ? ? Low
Murphy et al.
[70]
? ? ? ? ? ? ? Low
O’Leary et al.
[71]
? ? – ? ? ? ? Medium
Olley [72] ? ? ? ? ? ? ? Low
Pacella et al.
[73]
? ? ? ? ? ? ? Medium
Peltzer et al.
[74]
? ? ? ? ? ? ? Low
Petersen et al.
[75]
? ? – ? ? ? ? Medium
Ransom et al.
[76]
? ? ? ? ? ? ? Medium
Rao et al. [24] ? ? ? ? ? ? ? Low
Rotherham-
Borus et al.
[25]
? ? ? ? ? ? ? High
Safren et al.
[77]
? ? ? ? ? ? ? Medium
Safren et al.
[78]
? ? ? ? ? ? ? Medium
Sarna et al.
[22]
? ? ? ? ? ? ? Medium
SeyedAlinaghi
et al. [79]
? ? – ? ? ? ? Medium
Shuter et al.
[80]
? ? ? ? NA NA NA High
Sikkema et al.
[81–84]
? ? – ? ? ? ? Medium
Simoni et al.
[85]
? ? – ? ? ? ? Medium
Simoni et al.
[86]
? ? ? ? ? ? ? High
Stein et al. [26] ? ? – ? ? ? ? Medium
Szapocznik
et al. [87]
? ? ? ? ? ? ? High
Van Tam et al.
[88]
? ? – ? ? ? ? Low
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Publication Bias
When the funnel plot was inspected (see Fig. 4), it was
clear that studies were missing on the left side of the plot.
This may be an indication of publication bias. Egger’s test
of the intercept was significant, intercept 0.82, 95% CI
[0.09, 1.54], t(60) = 2.24, p\ 0.05. This also indicates
that there may be publication bias. Lastly, Duval and
Tweedie’s trim and fill analysis demonstrated that 14
studies were missing on the left side of the plot (see black
dots in Fig. 4). After imputation of these 14 studies, the
adjusted effect size was gˆ = 0.11, 95% CI [0.04, 0.17].
This effect size is substantially smaller than the unadjusted
effect size of gˆ = 0.19. In sum, there seems to be evidence
for publication bias in this meta-analysis, as studies with
smaller effect sizes are missing.
Moderator Analysis on the Outcome Depression
Table 5 shows the effects of the subgroup analysis on the
outcome depression. It shows that the type of control group
was a significant moderator. Contrary to expectations,
studies that used a waiting list control group had smaller
effect sizes in general, than studies that used an active or
standard care control condition. However, there were only
five studies in this analysis that used a waiting list control
group. Also, the percentage of people with AIDS in a study
was a significant moderator, i.e., when less than 40% of the
Table 3 continued
Study Sequence
generation
Allocation
concealment
Incomplete
outcome
data
Selective
outcome
reporting
Availability of
treatment
manual
Use of training
for therapy
providers
Treatment
integrity was
checked
Quality
classificationa
Vidrine et al.
[89]
? ? ? ? ? ? ? Low
Webel [90] ? ? ? ? ? ? ? Low
Weber et al.
[27]
? ? ? ? ? ? ? High
Williams et al.
[91]
? ? ? ? ? ? ? Medium
Williams et al.
[92]
? ? – ? ? ? ? Low
Williams et al.
[93]
? ? – ? ? ? ? Low
? low risk of bias, - high risk of bias; ? unclear risk of bias; NA = not applicable (e.g., when the intervention is a self-help program)
a quality classification, this was calculated by adding up the low risk of bias ratings (see ‘‘Method’’ section)
Fig. 2 Risk of bias graph
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Fig. 3 Forest plot showing the effect of psychosocial interventions on mental health outcomes
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participants in the studies had AIDS the effect sizes were
on average larger than when 40% or more of the partici-
pants in the studies had AIDS. Furthermore, the moderator
a priori screening on depression was significant, which
means that studies that only included participants with
depressive symptoms had larger effect sizes in general
(gˆ = 0.46, 95% CI [0.25, 0.68]), than studies that did not
had the presence of depressive symptoms as an inclusion
criterion (gˆ = 0.12, 95% CI [0.05, 0.18]). Last, the mod-
erator provider of the intervention was significant. Studies
that had a psychologist or a psychotherapist as a provider
of the intervention had the largest pooled effect sizes.
Studies that used other providers (e.g., a counsellor or peer
or a computer) had smaller pooled effect sizes. Concluding,
the moderators that were found to be significant were: type
of control group, percentage of people with AIDS, a priori
screening on depression, and provider of the intervention.
Moderator Analysis: Effect of Intervention
Characteristics on the Outcome Depression
Table 6 shows the effects of intervention characteristics on
the outcome of depression. In this analysis, all interven-
tions were investigated separately, so some studies are
Table 4 Overall analysis and
analysis separately for each
outcome, intervention type and
time point
Analysis Subgroup ka Hedges’ gˆ 95% CI Qb I2 (%)c
Overall effect 62 0.19d 0.13, 0.25 99.35d 39
Outcome Depression 47 0.21d 0.13, 0.29 87.32d 47
Anxiety 22 0.09 -0.01, 0.19 31.29 33
Quality of life 19 0.13d 0.04, 0.21 21.07 15
Psychological well-being 25 0.20d 0.09, 0.31 44.63d 46
Intervention type Symptom-oriented intervention 39 0.19d 0.11, 0.28 69.71d 46
Supportive intervention 20 0.21d 0.09, 0.33 43.58d 56
Meditation intervention 9 0.20d 0.06, 0.35 2.00 0
Time point Posttest 0–3 months 59 0.18d 0.12, 0.25 85.79e 32
Posttest 3–6 months 19 0.13d 0.05, 0.22 28.31 36
Posttest 6–9 months 12 0.18d 0.05, 0.31 22.97e 52
Posttest[9 months 9 0.08 -0.05, 0.21 13.79 42
a k = number of studies
b Q = heterogeneity test
c I2 = % of heterogeneity
d p\ 0.01
e p\ 0.05
Fig. 4 Funnel plot of standard
error by Hedges’s g with
imputed studies from Duval and
Tweedie’s trim and fill analysis
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Table 5 Moderators of intervention effect on depression (k = 47)
Moderator Subgroup ka Hedges’ gˆ 95% CI Q for differenceb
Control group Active control group 24 0.22c 0.11, 0.33 6.74d
Standard care 18 0.25c 0.14, 0.36
Waiting list 5 -0.04 -0.24, 0.16
Location Africa/Asia 8 0.19c 0.05, 0.33 0.01
North America/Europe 38 0.19c 0.10, 0.27
Othere 1
First year recruitment 1996–2001 16 0.13d 0.02, 0.24 4.37
2002–2006 15 0.32c 0.16, 0.47
2007–2012 13 0.13 -0.01, 0.28
Missing 3
% Attrition 0–10% 14 0.18d 0.01, 0.36 1.14
10–20% 17 0.20c 0.08, 0.32
[20% 14 0.28c 0.15, 0.41
Missing 2 0.03
% Females 0–20% 14 0.27c 0.15, 0.40 4.54
20–80% 22 0.21c 0.09, 0.33
80–100% 10 0.08 -0.06, 0.21
Missing 1
Mean age \42.40 years 19 0.14c 0.04, 0.24 0.74
C42.40 years 22 0.21c 0.09, 0.32
Missing 6
% MSMf 0% 10 0.10 -0.05, 0.24 0.50
[0% 10 0.17d 0.02, 0.31
Missing 27
% Participants with AIDS \40% 5 0.54c 0.38, 0.71 7.24c
C40% 5 0.19 -0.01, 0.38
Missing 37
Mean duration HIV \10.02 years 10 0.16 -0.05, 0.38 0.21
C10.02 years 13 0.22c 0.07, 0.38
Missing 24
% on ARTg \87% 10 0.34c 0.15, 0.52 0.00
C87% 12 0.34c 0.18, 0.49
Missing 25
Screening on depression No 37 0.12c 0.05, 0.18 9.13c
Yes 10 0.46c 0.25, 0.68
Mental health primary outcome No 6 0.17 -0.02, 0.36 0.19
Yes 41 0.22c 0.13, 0.30
Provider intervention Psychologist 13 0.42c 0.28, 0.56 12.92d
Counsellor 21 0.15c 0.05, 0.25
Peer 2 0.10 -0.04, 0.25
None 5 0.18 -0.19, 0.54
Other (practitioner) 1 0.06 -0.22, 0.33
Missing 5
Format intervention Group 19 0.23c 0.14, 0.33 4.58
Individual 20 0.25c 0.10, 0.40
Combination 4 0.09 -0.16, 0.33
Other 4 -0.01 -0.26, 0.23
Analysis ITTh 24 0.22c 0.11, 0.34 1.32
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represented twice. When mental health (i.e., depression,
anxiety, quality of life, or psychological well-being) was a
primary focus of the intervention in a study, the effect sizes
were in general larger than when mental health was not a
primary focus of an intervention. Furthermore, treatment
duration was a significant moderator. Studies with treat-
ment durations of 12–18 h had the largest effect sizes.
Studies with shorter or longer treatment durations had
smaller effect sizes in general. In sum, the following
moderators were significant in this analysis: mental health
primary focus of the intervention and treatment duration.
Moderator Analysis on the Outcome Psychological
Well-Being
The moderator analysis was also conducted on the outcome
psychological well-being, next to the moderator analysis on
the outcome depression. It was decided to do the moderator
analysis on these two outcomes, because the largest pooled
effect sizes were found for depression and psychological
well-being and heterogeneity was highest and significant
for these outcomes (see Table 4). Differences between the
moderator analysis on the outcome depression and psy-
chological well-being will be discussed here. The moder-
ators percentage of people with AIDS, provider of the
intervention, whether mental health was a primary focus of
the intervention and treatment duration were not significant
in the analysis on well-being, all p’s[ 0.06. The type of
control group remained a significant moderator. The
moderator screening on the presence of depressive symp-
toms was not included in this analysis, since the outcome
was psychological well-being and therefore most studies
did not screen on depressive symptoms in these studies.
Furthermore, the percentage of people on ART (Q = 4.10,
p\ 0.05) and study quality (Q = 8.71, p\ 0.05) were
significant moderators in this analysis. Regarding the per-
centage of people on ART, the largest effect sizes were in
general for studies with 87% or more of the participants on
ART (gˆ = 0.39, 95% CI [0.14, 0.64], p\ 0.01, k = 8),
and studies with less than 87% of participants on ART had
smaller effect sizes (gˆ = 0.07, 95% CI [-0.11, 0.25],
p = 0.45, k = 3). Though, the last category contained only
three studies. Regarding study quality, studies with a
medium quality had larger effect sizes on average
(gˆ = 0.30, 95% CI [0.14, 0.46], p\ 0.001, k = 14), than
studies with a low (gˆ = 0.15, 95% CI [-0.05, 0.35],
p = 0.15, k = 7) or high quality (gˆ = -0.04, 95% CI
[-0.21, 0.12], p = 0.61, k = 4). However, there were only
four studies in the category high quality in this analysis.
Summarizing, in the moderator analysis on the outcome
psychological well-being the significant moderators were:
type of control group, percentage of people on ART, and
study quality.
Discussion
The first aim of this systematic review and meta-analysis
was to investigate the effectiveness for PLWH of various
psychosocial interventions aimed at decreasing depression
and anxiety, and improving quality of life and psycholog-
ical well-being, and to investigate which interventions were
the most effective on these outcomes. Sixty-two studies
were included in the analysis, and it was found that psy-
chosocial interventions had a positive effect on the mental
health outcomes described, although the effect size was
small. In addition, there was evidence of publication bias,
so the corrected effect size was smaller. Most studies in the
Table 5 continued
Moderator Subgroup ka Hedges’ gˆ 95% CI Q for differenceb
No ITTh 15 0.13d 0.02, 0.24
Missing 8
Study quality Low 17 0.23c 0.08, 0.38 0.53
Medium 24 0.19c 0.09, 0.29
High 6 0.28d 0.001, 0.57
a k = number of studies
b Q = Q for difference between subgroups
c p\ 0.01
d p\ 0.05
e One study recruited participants in South Africa, Puerto Rico and the USA. This study could not be classified into one of the categories, so it
was removed from the moderator analysis on location
f MSM men that have sex with men
g ART antiretroviral therapy
h ITT intent to treat analysis
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meta-analysis were categorized as low or medium quality
studies, there was a lack of high quality studies. Further-
more, a range of psychosocial intervention types can be
effective for PLWH, from symptom-oriented interventions
such as CBT, to supportive interventions and meditation.
There were no differences in effectiveness between these
different intervention types, so they all seem to be helpful
in improving the mental health of PLWH.
The second aim of the current meta-analysis was to
study moderators of intervention effect, to determine
whether important characteristics of a study or a therapy
may influence the effectiveness of the treatments in ques-
tion. We found that six factors may influence the effec-
tiveness of a treatment for depression. Of these six factors,
three could be classified as intervention characteristics:
who provided the intervention, whether mental health was
a primary focus of the intervention, and what the duration
of treatment was. The other three were study characteris-
tics: whether there was a priori screening for depression,
what percentage of the participants in a study had AIDS,
and what type of control group was included. Other factors,
such as intervention techniques, were shown not to mod-
erate intervention effect.
We found that, overall, psychosocial interventions had a
positive effect on depression, anxiety, quality of life, and
psychological well-being of PLWH. However, the pooled
effect size was small, gˆ = 0.19. When the pooled effect
sizes of the separate outcomes were examined, it was found
that the pooled effect sizes on depression and psychologi-
cal well-being were the largest; smaller pooled effect sizes
were found on anxiety and quality of life. Previous meta-
analyses [14–16] found mostly small to moderate effect
sizes of psychosocial interventions for PLWH for the
outcomes depression and anxiety. The effect size on the
outcome quality of life was comparable with a previous
meta-analysis, which also found a small effect [16]. Fur-
thermore, two previous meta-analyses investigated the
effects of CBT and stress-management on stress (stress was
included in the outcome psychological well-being in the
present meta-analysis), and one of these found a moderate
[14] and the other a small pooled effect size [16]. These
differences in effect sizes between the current study and
previous ones may be explained by a difference in the
focus of the interventions included. When the moderator
analysis was conducted, it was found that when mental
health was the primary focus of an intervention, the effects
were larger than when this was not the primary focus of an
intervention. Previous meta-analyses mainly included
interventions whose primary aim was to improve mental
health. This important difference between the current meta-
Table 6 Effect of intervention characteristics on depression
Moderator Subgroup ma Hedges’ gˆ 95% CI Q for differenceb
Relaxation techniquec No 22 0.18d 0.06, 0.29 2.75
Yes 9 0.38d 0.17, 0.59
Cognitive behavioral techniquec No 9 0.15 -0.07, 0.38 0.53
Yes 22 0.25d 0.13, 0.37
Motivational interviewing techniquec No 25 0.23d 0.12, 0.34 0.07
Yes 6 0.18 -0.16, 0.52
Stress-management techniquec No 20 0.19d 0.06, 0.31 1.04
Yes 11 0.29d 0.13, 0.45
Mental health primary focus intervention No 22 0.14d 0.06, 0.22 4.02e
Yes 31 0.29d 0.02, 0.41
Theory-driven intervention No 19 0.22d 0.09, 0.36 0.01
Yes 34 0.21d 0.12, 0.31
Treatment duration 1–5 h 13 0.06 -0.09, 0.20 10.76e
5–12 h 14 0.12 -0.01, 0.25
12–18 h 11 0.38d 0.23, 0.53
18–30 h 9 0.17 -0.003, 0.33
Missing 6
a m = number of interventions
b Q = Q for difference between subgroups
c The effect of the use of specific intervention techniques was investigated in symptom-oriented interventions only (m = 31)
d p\ 0.01
e p\ 0.05
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analysis and previous meta-analyses may explain the
smaller effects in this study. In addition, the current meta-
analysis included 62 studies, while most previous meta-
analyses included less than half this number of studies. The
inclusion criteria of this meta-analysis were also broader:
various psychosocial interventions and outcomes were
included. For these reasons, this meta-analysis may have
more power to detect a true effect.
Furthermore, the analysis was conducted at several time
points, to study the effect of interventions in both the short
and the long term. It was found that the effect size was
much smaller at the last time point (9 months or more after
the intervention had ended), than at the earlier time points.
Two previous meta-analyses [14, 18] about the effective-
ness of CBT for PLWH with mental health problems also
found that the effects were smaller on later follow-up
assessments. This may indicate that the positive effects of
interventions on the mental health of PLWH may wear off
after a while. Booster sessions, follow-up sessions after
termination of the therapy to prevent relapse, could be
helpful to retain the effects. A similar finding emerged in a
meta-analysis about the long-term effects of psychotherapy
for depression [94]. However, only nine studies in our
meta-analysis had data available on the last time point, so
the results should be interpreted with caution. For future
studies into psychosocial interventions for PLWH with
mental health problems, we advise including a longer fol-
low-up period to further investigate the long-term effects.
In addition, future research could study the effect of
booster sessions.
In the analysis on intervention types, no differences
were found between the various intervention types. This is
in line with previous meta-analyses about psychological
therapies for depression in the general population or in
people with medical disorders, which also found no dif-
ferences in effectiveness between interventions such as
CBT, interpersonal therapy, supportive therapy, and prob-
lem-solving therapy [94–98]. It seems that several types of
interventions may be useful to improve the mental health of
PLWH. It has previously been argued more generally that
various forms of psychotherapy may have the same effect,
because they share common factors, such as the relation-
ship with the therapist [99, 100]. The specific type of
therapy does not seem to be that important. This corre-
sponds with our findings. For a more thorough investiga-
tion of the differences in effect between psychosocial
interventions for PLWH, it is important to design studies
that compare different types of interventions. Furthermore,
it would also be interesting to know more about how
treatments work (mediating factors), and to compare this
between different treatments. Future studies should focus
on these topics.
In addition to the analysis on intervention types, we also
investigated differences in effect between intervention
techniques in the symptom-oriented interventions. No dif-
ferences in effect were found between symptom-oriented
interventions that included techniques of relaxation, CBT,
stress-management, or motivational interviewing, on the
one hand, and symptom-oriented interventions that did not
include these techniques, on the other. This is related to the
findings about intervention types and a previous meta-
analysis that also did not find any differences between
interventions that included or did not include stress man-
agement skills training [14].
The subgroup analyses indicated that there were several
moderators that influenced the effects of interventions on
depression. An important moderator was a priori screening
for depressive symptoms: when studies included only
participants with depressive symptoms the effect sizes
were larger than when the presence of depressive symp-
toms did not serve as an inclusion criterion. This result
seems evident: there is more to gain for PLWH with
depressive symptoms than for PLWH without depressive
symptoms. A previous meta-analysis also found that in
studies that included PLWH with more anxiety symptoms
at baseline, the participants benefited more from stress-
management interventions [16]. On the other hand, another
meta-analysis into the effectiveness of CBT for PLWH
with depression and anxiety found no inclusion-related
differences between studies: there was no difference
between studies that restricted participation to those with
depressive symptoms and studies that did not have the
presence of depressive symptoms as an inclusion criterion
[14]. However, in this meta-analysis the number of studies
in each category was low. All in all, when an intervention
is aimed at reducing depression, it seems favorable to
screen PLWH a priori and only offer them the treatment if
they actually suffer from depressive symptoms.
Another significant moderator was whether mental
health was the primary focus of an intervention. In studies
where mental health was the primary focus of the inter-
vention, the effects were larger than in studies where mental
health was not the primary focus. Again, this result seems
logical: if the aim of an intervention is to reduce depression,
participants will work on reducing symptoms during treat-
ment, and it is expected that this will be effective. If the aim
of an intervention is to quit smoking, for example, this will
be the focus of the therapy and it is not so likely that par-
ticipants’ psychological symptoms will also improve.
We found that studies that had a psychologist or psy-
chotherapist as a provider of the intervention had the lar-
gest pooled effect sizes. Studies that had other providers,
e.g., counsellors, peers, or computers, all had smaller effect
sizes in general. This shows that it may not be so important
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which specific therapy or technique is used to treat mental
health problems in PLWH; the key element may be the
provider of the intervention. Psychologists have a broad
training in treating mental health problems, so they may be
more experienced and more competent to help PLWH in
need. This is in contrast with most other providers; they
may be trained to provide the intervention, but this may not
be comparable to psychologists’ education and experience
in mental health care. However, a previous meta-analysis
about CBT for depression and anxiety in PLWH found no
differences in effects between studies in which interven-
tions were provided by a psychologist or psychiatrist and
studies in which interventions were delivered by trained
research staff (e.g., graduate- and doctoral-level students)
[14]. Further, two meta-analyses on guided self-help [101]
or guided computerized interventions [102] for depression
or anxiety also did not find differences in effects between
studies involving experienced providers (e.g., psycholo-
gists) and those involving less experienced providers (e.g.,
students). However, the moderator analysis in this meta-
analysis comprised many more studies than those in the
previous meta-analyses, so it has more power to detect
differences. To conclude, psychologists and psychothera-
pists may be the most qualified providers of psychosocial
treatments for PLWH with mental health problems. More
research is needed to confirm this.
The duration of treatment was another important mod-
erator in this meta-analysis. We found that studies with a
treatment duration of 12–18 h had the largest effect sizes,
compared to treatments of shorter or longer duration. So, it
seems that therapies of average duration may be more
effective than treatments of short or long duration. How-
ever, there is a trend toward designing concise treatments
for mental health problems, which can be provided via the
Internet and are thought to be more cost-effective. An RCT
that compared the effectiveness of concise CBT with
standard CBT for depression and anxiety found that they
were equivalent [103]. Most previous meta-analyses that
have investigated the effectiveness of psychological inter-
ventions for depression or anxiety have also found no
differences between treatments with a short or long dura-
tion [14, 95, 97, 101, 102]. One meta-analysis about online
CBT for patients with chronic somatic conditions and
depression did find an effect of treatment duration, with a
larger effect size for treatments with a longer duration
[104]. Some of the previous meta-analyses
[14, 101, 102, 104] included a small number of studies in
the moderator analysis, but other meta-analyses [95, 97]
included more than 100 studies. Hence, it is not yet clear
whether the effectiveness of a treatment is related to its
duration. When comparing short and long treatments for
mental health problems, it may be useful to take the
severity of the symptoms into account. People with more
severe symptoms may need more sessions than people with
a mild or moderate symptom severity [105]. Future studies
may focus on this topic.
Contrary to expectations, the type of control group was
a significant moderator in this meta-analysis. Studies that
had a waiting list control group had smaller effect sizes
than studies with a standard care or active control group.
This is counterintuitive, since participants on a waiting list
do not receive any treatment, which would lead us to
expect large differences between the intervention and the
control condition [106]. However, there were only five
studies in the moderator analysis that used a waiting list
control condition, so firm conclusions cannot be drawn.
Previous meta-analyses on the effectiveness of interven-
tions for depression and anxiety found no differences
between control group types [14, 94, 102], or found that
the studies that used a waiting list control condition had
larger effect sizes than other control group types
[95, 101, 102].
The last significant moderator was the percentage of
participants in the study who had AIDS. When fewer than
40% of the participants in a study had received a diagnosis
of AIDS, the effect sizes were larger than when more than
40% of the participants had AIDS. People with AIDS are
generally more physically ill—they suffer from more pain
and lack of energy—than people without AIDS. This
physical discomfort may have a great influence on their
mental well-being: i.e., they may feel more sad, worry
more, or have difficulties sleeping [1]. Therefore, it may be
more difficult to treat these psychological symptoms in
people with AIDS. That is, the physical symptoms remain,
and their influence on the mental state may hamper a
successful response to treatment. Therefore, it may be
important to combine medical and psychosocial treatments
in people with AIDS, to try to improve or stabilize both the
physical and psychological symptoms. In this situation,
effective collaboration between treatment providers is
crucial. It should be noted that this moderator analysis was
based on only ten studies, so the results should be inter-
preted cautiously and may not be generalizable to other
study samples.
This meta-analysis had some limitations, which will be
discussed here. First, there was evidence of publication
bias. This may indicate that studies with negative effect
sizes were missing in the analysis. When these possible
missing studies were imputed and a corrected effect size
was calculated, it was smaller than the uncorrected effect
size. So, it has to be concluded that the overall effect of
psychosocial interventions on the mental health of PLWH
is small. Second, the quality of the studies included was
mostly low or medium; only 16% of the studies included
was of high quality. The quality criteria regarding the
concealment of allocation to conditions and the availability
36 AIDS Behav (2018) 22:9–42
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of a published study protocol, especially, were often not
clearly reported in the studies included. Therefore, it is
possible that some studies were classified as low or med-
ium quality studies now, while they may have been clas-
sified as high quality studies when there would be more
information in the paper concerning these criteria. Besides
this, it is evident that low quality studies often did not do an
intent-to-treat analysis. It would be advisable for future
studies to state whether they have complied with the cri-
teria, and that incomplete outcome data will be adequately
addressed. A limitation of the instruments used to assess
study quality is that when many criteria are not clearly
described in a paper, a study was classified as a low quality
study. However, study quality was not a significant mod-
erator in the analysis on depression, so studies of high
quality did not have larger effect sizes than studies of lower
quality. Third, in some of the moderator analyses, only a
few studies could be included. This is related to the fact
that some studies did not report on all moderator variables.
Consequently, the results of the moderator analyses with
few studies may not be representative for all of the studies
included, and the power is lower in these analyses. Fourth,
many moderator analyses were performed in this study, and
no correction for multiple testing was applied. This
increases the risk of finding spurious moderator effects.
Fifth, the outcomes in this meta-analysis were restricted, so
the effect of psychosocial interventions on other relevant
outcomes (e.g., PTSD) was not investigated. Though, a
recent review [107] found two CBT-based interventions
that were effective in decreasing PTSD symptoms in
PLWH. Therefore, it is possible that the findings of the
current meta-analysis also apply to PTSD. However, only
two studies were found in the review, so more research into
interventions for PTSD in PLWH is necessary. Sixth,
although we searched in three databases and in the refer-
ences of previous meta-analyses and reviews, it is still
possible that some relevant articles were not found with
this search strategy. Seventh, the moderator concerning the
theory content of the intervention had two categories:
theory driven or not theory-driven. For each study, it was
determined to which of the categories it belonged by
reading the paper. It could be argued that this is not a
completely thorough approach, because an intervention
may still be based on theory, despite the fact that it is not
stated in the paper. Furthermore, interventions may be
evidence-based, but not based on a specific theory. Or the
other way around: it may be based on a theory, but it is not
evidence-based. So, it is recommended for future studies to
mention in the paper whether the investigated intervention
was theory-driven and/or evidence-based. Last, in the
moderator analysis on the effect of intervention charac-
teristics, all interventions were investigated separately.
This approach was chosen because in some studies two
interventions were investigated, and the interventions did
not always belong to the same category of a moderator
(e.g., one intervention in a given study may have a treat-
ment duration of 4 h and another a treatment duration of
8 h). Therefore, six studies were represented twice in these
analyses. It would be preferable to use each study just once
in the analysis, but this was not possible here.
Some recommendations for future research may be
derived from the results of this meta-analysis. First, future
studies should focus on investigating differences between
various interventions: how they work and for whom they
work. Second, the long-term effects of psychosocial
interventions and the effect of booster sessions should be
investigated more thoroughly in the future. Third, most
studies in the current meta-analysis were conducted in the
USA and in Europe. Since the prevalence of HIV is high
in low and middle income countries and mental health
problems are common in this population, interventions to
treat these problems are needed [108]. However, there are
significant barriers to providing mental health services in
these countries, e.g., there is a lack of trained mental
health workers [109]. Therefore, it is important that these
interventions are adapted to the local culture, are brief,
can be provided by non-specialists, and are tailored for
PLWH. It was found that interventions for PLWH in low
and middle income countries were effective when they
were focused on the family and integrated into community
based health care [110]. More research is recommended
on mental health interventions for PLWH in low and
middle income countries. Fourth, there were a lot of
changes in the past twenty years in the mental health care
for PLWH and in study methodologies. We investigated
the effects of many moderators, but there will be issues
that were not addressed. For future studies, it is important
to be aware of the changes in mental health care and study
design. Fifth, it is likely that moderator effects were
related, e.g., when there was a screening for depression in
a study, this may be related to the fact that the primary
focus of the intervention in the study was on mental
health. These relations between moderators were not
examined in the current meta-analysis, but are interesting
to investigate in future meta-analyses. The most optimal
result of an intervention may be obtained when the most
effective characteristics will be combined in an interven-
tion. Sixth, the moderation analysis indicated that the
effect sizes were larger for studies that solely included
PLWH with mental health problems and for interventions
that were focused on mental health. Therefore, it is rec-
ommended in future intervention studies to restrict the
inclusion to participants with mental health problems and
to design interventions that are focused on improving
mental health. Last, for new studies, it is important to
measure and report on study and treatment characteristics,
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so that studies and interventions can be compared in meta-
analyses.
To conclude, this systematic review and meta-analysis
included 62 RCTs and therefore has high power. In addi-
tion, the effects of multiple intervention and study char-
acteristics on treatment outcome were investigated. The
meta-analysis found that, overall, psychosocial interven-
tions may have a small positive effect on the mental health
of PLWH. No differences in effect were found between the
three intervention types, which means that symptom-ori-
ented interventions, supportive interventions, and medita-
tion may all be effective. A larger improvement in
depression may be obtained when only participants with
depressive symptoms are included in the study; when
interventions are provided by psychologists; when treat-
ment duration is 12–18 h; and when the intervention is
focused on improving mental health. Based on the results
of this meta-analysis, it is important to incorporate psy-
chosocial therapies into the care of PLWH with mental
health problems.
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Appendix: Search Strategy
PubMed Search Term
(hiv [mesh] OR hiv infection [mesh] OR hiv [tiab] or aids
[tiab]) AND (psychotherapy [mesh] OR mental health
services [mesh] OR self-care [mesh] OR self-help groups
[mesh] OR telemedicine [mesh] OR therapy, computer-
assisted [mesh] OR psychotherap* [tiab] OR psychological
therap* [tiab] OR psychological treatment* [tiab] OR
psychological intervention* [tiab] OR counsel* [tiab] OR
cbt [tiab] OR behavior therap* [tiab] OR behaviour therap*
[tiab] OR interpersonal therap* [tiab] OR coping [tiab] OR
peer support [tiab] OR social support [tiab] OR problem
solving [tiab] OR stress manage* [tiab] OR self-help [tiab]
OR internet therap* [tiab] OR online therap* [tiab] OR
psychoed* [tiab] OR training [tiab] OR exposure [tiab] OR
relaxation [tiab] OR mindfulness [tiab] OR reinforcement
[tiab] OR risk reduction [tiab] OR commitment therap*
[tiab] OR case manage* [tiab]) AND (depression [mesh]
OR depress* [tiab] OR anxiety [mesh] OR anxi* [tiab] OR
fear [tiab] OR quality of life [mesh] OR quality-of-life
[tiab] OR well-being [tiab] OR stress, psychological
[mesh] OR stress* [tiab] OR distress [tiab] OR mental
health [tiab])
Filters used controlled clinical trial or randomized con-
trolled trial, publication date from 1996/01/01, humans,
English language.
PsycInfo Search Term
(DE (hiv OR aids) OR TX (hiv OR aids)) AND (DE (psy-
chotherapy OR psychotherapeutic techniques OR mental
health programs OR Counseling OR Stress management
OR case management OR self management OR Tele-
medicine OR Computer Assisted Therapy OR Psychoedu-
cation) OR TX (psychotherap* OR psychological-therap*
OR psychological-treatment OR psychological-intervention
OR counsel* OR cbt OR behavio#r-therap* OR interper-
sonal-therap* OR coping OR peer-support OR social-sup-
port OR problem-solving OR stress-manage* OR self-help
OR internet-therap* OR online-therap* OR psychoed* OR
training OR exposure OR relaxation OR mindfulness OR
reinforcement OR risk-reduction OR commitment-therap*
OR case-manage*)) AND (DE (major depression OR anx-
iety OR stress OR distress OR quality of life OR well being)
OR TX(depress* OR anxi* OR fear OR quality-of-life OR
well-being OR stress* OR distress OR mental-health))
Filters used publication year 1996–2015, adulthood (18
years and older), experimental replication or treatment
outcome/clinical trial or follow-up study.
Embase Search Term
(exp ‘‘Human immunodeficiency virus’’/OR exp ‘‘Human
immunodeficiency virus infection’’/OR exp ‘‘Acquired
immune deficiency syndrome’’/OR hiv.tw. OR aids.tw.)
AND (exp psychotherapy/or exp ‘‘mental health services’’/
or exp ‘‘self care’’/OR exp ‘‘self help’’/OR exp teletherapy/
OR exp ‘‘computer assisted therapy’’/OR psychother-
ap*.tw. OR psychological-therapy.tw. OR psychological-
treatment.tw. OR psychological-intervention.tw. OR
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counsel*.tw. OR cbt.tw. OR behavio?r-therapy.tw. OR
interpersonal-therapy.tw. OR coping.tw. OR peer-sup-
port.tw. OR social-support.tw. OR problem-solving.tw. OR
stress-management.tw. OR self-help.tw. OR internet-ther-
ap*.tw. OR online-therap*.tw. OR psychoed*.tw. OR
training.tw. OR exposure.tw. OR relaxation.tw. OR mind-
fulness.tw. OR reinforcement.tw. OR risk-reduction.tw.
OR commitment-therap*.tw. OR case-manage*.tw.) AND
(exp depression/OR depress*.tw. OR exp anxiety/OR
anxi*.tw. OR exp fear/OR fear.tw. OR ‘‘quality of life’’/
exp OR quality-of-life.tw. OR well-being.tw. OR exp
stress/OR ‘‘mental stress’’/exp OR stress*.tw. OR dis-
tress.tw. OR mental-health.tw.)
Filters used human, English language, records from
Embase, randomized controlled trial or controlled clinical
trial, publication year 1996–2015, article and adult
(18–64 years) or aged (65? years).
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